Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

TSXV:CLAS.H - Post Discussion

View:
Post by Ettycallin0612 on Apr 29, 2020 12:48pm

kly question

Why is Stero Bio Tech advertising on their webpage that they have a phase 2 GVHD product ?
Comment by Theknocker91 on Apr 29, 2020 1:01pm
Stero has had a program for reducing steroid usage in gvhd treatment but not treating gvhd itself
Comment by Jack4000 on Apr 29, 2020 1:19pm
This post has been removed in accordance with Community Policy
Comment by Dude51 on Apr 29, 2020 1:02pm
Just send us the link moron who just joined today.
Comment by Ettycallin0612 on Apr 29, 2020 1:07pm
this is a legit question douche bag..........  went to Stero Bio tech on google and clicked on Stero Bio TEch not rocket science! I have alot invested also ...Now I see why people dont want to join this bullboard. Have a good day moron
Comment by Dude51 on Apr 29, 2020 1:19pm
but why should I go looking for it, I am basically a lazy moron, you just joined SH today and your posting some garbage attacking our stock basically acting like a basher moron. You do not know how to copy and paste a link to back up your statement, then your the moron, give us a link.
Comment by Ettycallin0612 on Apr 29, 2020 1:33pm
https://sterobiotechs.com/  click and read under the Opportunity 
Comment by Theknocker91 on Apr 29, 2020 1:16pm
Why so mad, shill
Comment by Ettycallin0612 on Apr 29, 2020 1:25pm
my intent was to ask an honest question and get a reply it didnt warrant such  the disresepectful reply on my post......IMO
Comment by Theknocker91 on Apr 29, 2020 1:31pm
Looking4doubles and dude51 are Israeli shills, don't take it personally.
Comment by Ettycallin0612 on Apr 29, 2020 1:35pm
thank you, dont usually respond to things like this , caught me off guard... 
Comment by Theknocker91 on Apr 29, 2020 1:48pm
Yeah most of the other pumpers have jumped ship but those two defend this company so virulently that they must be getting paid for it by either KALY or talent/stero
Comment by indaknownewfie on Apr 29, 2020 1:54pm
If you go back to the initial news release where Kaly a nounced it was buying Stero, among the 130 ailments that were listed, GvHD was listed there 
Comment by Dude51 on Apr 29, 2020 2:13pm
I think were still going to be okay, why? We have patents and or patents pending I believe. https://www.stockwatch.com/News/Item?bid=Z-C%3aKLY-2765691&symbol=KLY&region=C https://www.stockwatch.com/News/Item?bid=Z-C%3aKLY-2816068&symbol=KLY&region=C https://www.stockwatch.com/News/Item?bid=Z-C%3aKLY-2862359&symbol=KLY&region=C GLTA
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities